Skip to main content

CORRECTION article

Front. Pharmacol., 28 May 2024
Sec. Respiratory Pharmacology
Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1428213

Corrigendum: Effect of elexacaftor-tezacaftor-ivacaftor on nasal potential difference and lung function in Phe508del rats

This article is a correction to:

  1. Effect of elexacaftor-tezacaftor-ivacaftor on nasal potential difference and lung function in Phe508del rats

    1. Read original article
Nicole Reyne,, Nicole Reyne1,2,3*Patricia Cmielewski,,Patricia Cmielewski1,2,3Alexandra McCarron,,Alexandra McCarron1,2,3Ronan Smith,,Ronan Smith1,2,3Elena Schneider-FutschikElena Schneider-Futschik4Nina EikelisNina Eikelis5Piraveen PirakalathananPiraveen Pirakalathanan4David Parsons,,David Parsons1,2,3Martin Donnelley,,Martin Donnelley1,2,3
  • 1Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia
  • 2Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia
  • 3Respiratory and Sleep Medicine, Women’s and Children’s Hospital, Adelaide, SA, Australia
  • 4Department of Biochemistry and Pharmacology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC, Australia
  • 54DMedical, Carlton, VIC, Australia

A Corrigendum on
Effect of elexacaftor-tezacaftor-ivacaftor on nasal potential difference and lung function in Phe508del rats

by Reyne N, Cmielewski P, McCarron A, Smith R, Eikelis N, Pirakalathanan P, Parsons D and Donnelley M (2024). Front. Pharmacol. 15:1362325. doi: 10.3389/fphar.2024.1362325

In the published article, there was an error in the author list, and author Elena Schneider-Futschik was erroneously excluded. Consequently, the affiliation of the author Elena Schneider-Futschik is now added to the published article as affiliation 4 “Department of Biochemistry and Pharmacology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Australia”. The original affiliation 4 (4DMedical, Victoria, Australia) is now renumbered to affiliation 5

The corrected author list appears below.

Nicole Reyne, Patricia Cmielewski, Alexandra McCarron, Ronan Smith, Elena Schneider-Futschik, Nina Eikelis, Piraveen Pirakalathanan, David Parsons and Martin Donnelley

The Author Contributions section is also updated to reflect the addition of the author Elena Schneider-Futschik. The correct Author Contributions section appears below.

Author contributions

NR: Writing–original draft, Writing–review and editing, Data curation, Methodology, Formal Analysis. PC: Writing–review and editing, Data curation, Methodology, Supervision. AM: Writing–review and editing, Data curation, Methodology, Supervision. RS: Writing–review and editing, Data curation, Formal Analysis. ES-F: Writing–review and editing, Conceptualization, Funding acquisition. NE: Writing–review and editing. PP: Writing–review and editing. DP: Writing–review and editing, Supervision, Methodology. MD: Supervision, Writing–review and editing, Data curation, Methodology.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: cystic fibrosis, rat model, nasal potential difference, CFTR modulator, lung function, X-ray velocimetry

Citation: Reyne N, Cmielewski P, McCarron A, Smith R, Schneider-Futschik E, Eikelis N, Pirakalathanan P, Parsons D and Donnelley M (2024) Corrigendum: Effect of elexacaftor-tezacaftor-ivacaftor on nasal potential difference and lung function in Phe508del rats. Front. Pharmacol. 15:1428213. doi: 10.3389/fphar.2024.1428213

Received: 06 May 2024; Accepted: 10 May 2024;
Published: 28 May 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Reyne, Cmielewski, McCarron, Smith, Schneider-Futschik, Eikelis, Pirakalathanan, Parsons and Donnelley. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Nicole Reyne, bmlra2kucmV5bmVAYWRlbGFpZGUuZWR1LmF1

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.